ViaDerma, Inc.
VDRM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$322 | – | $88 | $40 |
| Dep. & Amort. | $0 | – | $0 | $0 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $0 | – | $0 | $0 |
| Change in WC | -$553 | – | $280 | -$90 |
| Other Non-Cash | $0 | – | $0 | $50 |
| Operating Cash Flow | -$875 | – | $368 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | – | $0 | $0 |
| Net Acquisitions | $0 | – | $0 | $0 |
| Inv. Purchases | $0 | – | $0 | $0 |
| Inv. Sales/Matur. | $0 | – | $0 | $0 |
| Other Inv. Act. | $0 | – | $0 | $0 |
| Investing Cash Flow | $0 | – | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,540 | – | $0 | $0 |
| Stock Issued | $0 | – | $0 | $0 |
| Stock Repurch. | $0 | – | $0 | $0 |
| Dividends Paid | $0 | – | $0 | $0 |
| Other Fin. Act. | $0 | – | $0 | $0 |
| Financing Cash Flow | $1,540 | – | $0 | $0 |
| Forex Effect | $0 | – | $0 | $0 |
| Net Chg. in Cash | $665 | – | $368 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $826 | – | $10 | $10 |
| End Cash | $1,491 | – | $378 | $10 |
| Free Cash Flow | -$875 | – | $368 | $0 |